Latest News and Press Releases

BOSTON and DURHAM, N.C., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...

Parexel leaders recognized as two of the 100 most inspiring people in life sciences for their transformative efforts to drive equity and innovation across the industry BOSTON and DURHAM, N.C., Aug. ...

BOSTON and DURHAM, N.C., July 28, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...

BOSTON and DURHAM, N.C., July 22, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...

BOSTON and DURHAM, N.C., July 07, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...

BOSTON dan DURHAM, N.C., July 07, 2021 (GLOBE NEWSWIRE) -- Parexel, sebuah organisasi riset klinis global (CRO/clinical research organization) terkemuka yang berfokus pada pengembangan dan...

BOSTON y DURHAM, Carolina del Norte, July 06, 2021 (GLOBE NEWSWIRE) -- Parexel, una organización líder mundial de investigación clínica (CRO) centrada en el desarrollo y entrega de nuevas terapias...

ボストンおよびノースカロライナ州ダーラム発, July 07, 2021 (GLOBE NEWSWIRE) -- 患者の健康を増進するために革新的な治療薬の開発･提供に注力する国際的な大手医薬品開発業務受託機関 (CRO) であるパレクセル (Parexel) は本日、最終的な合併契約締結を発表した。この契約の下、同社は (先にパレクセル株式を買収した) パンプローナ･キャピタル･マネジメント...

波士頓及北卡羅來納州達勒姆, July 07, 2021 (GLOBE NEWSWIRE) -- Parexel 是一家領先的全球臨床研究組織，專注開發和提供創新的新療法以促進患者健康，今天宣佈執行最終合併協議，公司將被 EQT IX 基金（「EQT Private Equity」）以及 Pamplona Capital Management LP 旗下的 Goldman Sachs...

波士顿和北卡罗来纳州达勒姆, July 07, 2021 (GLOBE NEWSWIRE) -- 专注于开发和提供创新疗法以促进患者健康的全球领先临床研究机构（CRO）Parexel今天宣布了一项最终合并协议的执行。根据该协议，EQT IX基金（“EQT Private Equity”）和Goldman Sachs Asset Management旗下私募股权业务部门（“Goldman...